Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “the Haploidentical Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06008808
What this trial is testing

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseGraft Versus Host Disease
Washington University School of Medicine 41
Not applicableStudy completedNCT07003269
What this trial is testing

Observational Study: Hetrombopag for Platelet Recovery in Haploidentical HSCT

Who this might be right for
Thalassemia in Children
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine 30
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Not applicableUnknownNCT05335226
What this trial is testing

Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Who this might be right for
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China 116
Not applicableLooking for participantsNCT06674382
What this trial is testing

Haplo-HSCT for Myelofibrosis

Who this might be right for
Myelofibrosis
Peking University People's Hospital 39
Not applicableStudy completedNCT02880293
What this trial is testing

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Who this might be right for
Hematologic Malignancy
Memorial Sloan Kettering Cancer Center 44
Testing effectiveness (Phase 2)Looking for participantsNCT03300492
What this trial is testing

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University Hospital, Basel, Switzerland 10
Early research (Phase 1)Study completedNCT02167958
What this trial is testing

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

Who this might be right for
LeukemiaMDSMyelofibrosis+1 more
Rafic Farah, MD 28
Large-scale testing (Phase 3)Looking for participantsNCT06202625
What this trial is testing

Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT

Who this might be right for
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital 142
Not applicableStudy completedNCT02414113
What this trial is testing

Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell TransplantationStem Cell Transplantation, HematopoieticTransplantation, Hematopoietic Stem Cell
Washington University School of Medicine 113
Testing effectiveness (Phase 2)Study completedNCT01794299
What this trial is testing

Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 31
Large-scale testing (Phase 3)Study completedNCT03719534
What this trial is testing

Haplo HCT vs Haplo-cord HCT for Patients With AML

Who this might be right for
Hematopoietic Stem Cell TransplantationHaplo-identical DonorCord Blood Unit+1 more
The First Affiliated Hospital of Soochow University 134
Large-scale testing (Phase 3)Looking for participantsNCT07689630
What this trial is testing

Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT

Who this might be right for
Graft Versus Host DiseaseHematologic Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186
Not applicableUnknownNCT03423706
What this trial is testing

Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
CD19-chimeric Antigen Receptor T CellsRelapsed and/or Refractory Acute Lymphoblastic Leukemiathe Haploidentical Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Harbin Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Testing effectiveness (Phase 2)Study completedNCT02985775
What this trial is testing

Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation

Who this might be right for
CMV Infection
Peking University People's Hospital 41
Large-scale testing (Phase 3)Looking for participantsNCT07702578
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Not applicableLooking for participantsNCT07693881
What this trial is testing

Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
EBV Infection After Allogenic HSCT
Nanfang Hospital, Southern Medical University 106
Testing effectiveness (Phase 2)WithdrawnNCT04024384
What this trial is testing

Daratumumab as Maintenance After Peripheral Blood Stem Cell Transplantation From HLA-identical or Haploidentical Family Donor in the Treatment of Refractory or Relapsed Multiple Myeloma: a Phase 2 Trial

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris
Early research (Phase 1)Study completedNCT03755414
What this trial is testing

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndromes+2 more
Washington University School of Medicine 55
Next Page